AbbVie
ABBV
ABBV
4,100 hedge funds and large institutions have $301B invested in AbbVie in 2025 Q4 according to their latest regulatory filings, with 427 funds opening new positions, 1,593 increasing their positions, 1,633 reducing their positions, and 126 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
1% less call options, than puts
Call options by funds: $2.85B | Put options by funds: $2.87B
2% less repeat investments, than reductions
Existing positions increased: 1,593 | Existing positions reduced: 1,633
8% less funds holding in top 10
Funds holding in top 10: 215 → 198 (-17)
Holders
4,100
Holding in Top 10
198
Calls
$2.85B
Puts
$2.87B
Top Buyers
| 1 | +$1.53B | |
| 2 | +$1.18B | |
| 3 | +$1.12B | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$1,000M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$955M |
Top Sellers
| 1 | -$943M | |
| 2 | -$540M | |
| 3 | -$455M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$409M |
| 5 |
Morgan Stanley
New York
|
-$367M |